2021
DOI: 10.1016/j.bbrc.2021.05.068
|View full text |Cite
|
Sign up to set email alerts
|

The tyrosine phosphatase SHP2 promotes proliferation and oxaliplatin resistance of colon cancer cells through AKT and ERK

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 27 publications
0
6
0
Order By: Relevance
“…Although oxaliplatin is very effective for cancers in the initial period, the resistance occurs eventually. Mechanisms of the resistance include the induction of multidrug resistance efflux transporter, ABCG2 (Hsu et al, 2018), YTH m6A RNA‐binding protein 3 (YTHDF3) (Zhao et al, 2022), and SH2 domain‐containing phosphatase 2 (Yu et al, 2021). Ech exhibited similar cytotoxicity and induced apoptosis in both oxaliplatin‐sensitive and ‐resistance cells (Figures 1 and 3).…”
Section: Discussionmentioning
confidence: 99%
“…Although oxaliplatin is very effective for cancers in the initial period, the resistance occurs eventually. Mechanisms of the resistance include the induction of multidrug resistance efflux transporter, ABCG2 (Hsu et al, 2018), YTH m6A RNA‐binding protein 3 (YTHDF3) (Zhao et al, 2022), and SH2 domain‐containing phosphatase 2 (Yu et al, 2021). Ech exhibited similar cytotoxicity and induced apoptosis in both oxaliplatin‐sensitive and ‐resistance cells (Figures 1 and 3).…”
Section: Discussionmentioning
confidence: 99%
“…This evidence holds potential therapeutic promise in light of the beneficial effects of metformin as an anti-fibrotic mediator through AMPK activation [ 34 ]. Finally, it is also interesting that another mediator of cancer, SHP2, is a potential therapeutic target for pulmonary fibrosis [ 35 , 36 , 37 ]. Focusing on commonalities between cancer and pulmonary fibrosis might lead to novel anti-fibrotic compounds, similarly with the process of nintedanib repositioning [ 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…( 146 ) and Yu M et al. ( 147 ) demonstrated that PTPN11 promotes vascular growth and proliferation of colon cancer cells as well as resistance to oxaliplatin through AKT and Erk signaling pathways. However, Yuan H et al.…”
Section: Dual Role Of Ptpns In Specific Cancersmentioning
confidence: 99%